Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2001Emerging infectious diseasesOpen Access

Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureus

View Full Paper
Ask AI
Bookmark
Share

Authors

Fred C. Tenover
Fred C. TenoverCreighton UniversityJBJames W. BiddleBrigham and Women's HospitalMLMichael V. LancasterKern Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tenover et al. (2001) studied this question.

synapsesocial.com/papers/6a16f8cdb082e78ad77bbca1https://doi.org/10.3201/eid0702.010237
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Historical Yearly Usage of Vancomycin1998 · 277 citations
  2. 2New Resistance in<i>Staphylococcus aureus</i>1999 · 130 citations
  3. 3Combinations of Vancomycin and β-Lactams Are Synergistic against Staphylococci with Reduced Susceptibilities to Vancomycin1999 · 191 citations
  4. 4Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility1997 · 1,993 citations
  5. 5Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf area1999 · 182 citations